By Chris Fall, Yong-Bee Lim, and Christine Parthemore The COVID-19 crisis has forcefully demonstrated both the seriousness of the threat posed by natural and anthropogenic biological risks and the incredible strides gained in modern biotechnology to address these risks, such as with the novel RNA-based vaccines developed to help halt the pandemic. In this context,…